Recently Viewed

News Announcement

Lupin: Announcement under Regulation 30 (LODR)-Press Release / Media Release

27-Dec-2023 Follow Value Research Online on Google download pdfDownload PDF Lupin

Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension 0.2%.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.